In addition to this biomarker, the hepatic microenvironment generally, and CD68+ hepatic macrophages in particular, express multiple genes and proteins associated with macrophage-targeting molecules already under study for the treatment of other liver diseases, as well as cancer. Here, CD68 is linked to liver disorder.